MS-DRG v44.0 · MDC 10: Endocrine, Nutritional and Metabolic Diseases and Disorders
643 — Endocrine Disorders with MCC
- Relative weight
- 1.6139
- Geometric mean LOS
- 4.8 days
- Arithmetic mean LOS
- 6.1 days
- Type
- Medical
About MS-DRG 643
MS-DRG 643, Endocrine Disorders with MCC, is a medical DRG in MDC 10 (Endocrine, Nutritional and Metabolic Diseases and Disorders) under MS-DRG version 44.0, which applies to inpatient discharges from October 1, 2026 through September 30, 2027.
Its FY2027 relative weight is 1.6139, so Medicare's base payment for this DRG is about 1.61 times the average inpatient case, before hospital-specific adjustments. The geometric mean length of stay is 4.8 days and the arithmetic mean is 6.1 days.
It belongs to a 3-level severity family: DRG 643 (with MCC, weight 1.6139), DRG 644 (with CC, weight 1.0044) and DRG 645 (without CC/MCC, weight 0.7459). The highest-severity level carries 2.2 times the weight of the lowest, which is why documenting CC and MCC conditions matters.
It is subject to Medicare's post-acute care transfer policy, so payment can be reduced when a patient with a shorter-than-average stay is discharged to a skilled nursing facility, home health or another post-acute setting.
199 ICD-10-CM diagnosis codes are part of this DRG's grouping logic; they are listed below.
ICD-10-CM codes that group to DRG 643 (199)
Chapter 1: Certain infectious and parasitic diseases
Chapter 2: Neoplasms
- C73Malignant neoplasm of thyroid gland
- C74.00Malignant neoplasm of cortex of unspecified adrenal gland
- C74.01Malignant neoplasm of cortex of right adrenal gland
- C74.02Malignant neoplasm of cortex of left adrenal gland
- C74.10Malignant neoplasm of medulla of unspecified adrenal gland
- C74.11Malignant neoplasm of medulla of right adrenal gland
- C74.12Malignant neoplasm of medulla of left adrenal gland
- C74.90Malignant neoplasm of unspecified part of unspecified adrenal gland
- C74.91Malignant neoplasm of unspecified part of right adrenal gland
- C74.92Malignant neoplasm of unspecified part of left adrenal gland
- C75.0Malignant neoplasm of parathyroid gland
- C75.1Malignant neoplasm of pituitary gland
- C75.2Malignant neoplasm of craniopharyngeal duct
- C75.8Malignant neoplasm with pluriglandular involvement, unspecified
- C75.9Malignant neoplasm of endocrine gland, unspecified
- C79.70Secondary malignant neoplasm of unspecified adrenal gland
- C79.71Secondary malignant neoplasm of right adrenal gland
- C79.72Secondary malignant neoplasm of left adrenal gland
- D13.7Benign neoplasm of endocrine pancreas
- D34Benign neoplasm of thyroid gland
- D35.00Benign neoplasm of unspecified adrenal gland
- D35.01Benign neoplasm of right adrenal gland
- D35.02Benign neoplasm of left adrenal gland
- D35.1Benign neoplasm of parathyroid gland
- D35.2Benign neoplasm of pituitary gland
- D35.3Benign neoplasm of craniopharyngeal duct
- D35.7Benign neoplasm of other specified endocrine glands
- D35.9Benign neoplasm of endocrine gland, unspecified
- D44.0Neoplasm of uncertain behavior of thyroid gland
- D44.10Neoplasm of uncertain behavior of unspecified adrenal gland
- D44.11Neoplasm of uncertain behavior of right adrenal gland
- D44.12Neoplasm of uncertain behavior of left adrenal gland
- D44.2Neoplasm of uncertain behavior of parathyroid gland
- D44.3Neoplasm of uncertain behavior of pituitary gland
- D44.4Neoplasm of uncertain behavior of craniopharyngeal duct
- D44.9Neoplasm of uncertain behavior of unspecified endocrine gland
- D49.7Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system
Chapter 4: Endocrine, nutritional and metabolic diseases
- E00.0Congenital iodine-deficiency syndrome, neurological type
- E00.1Congenital iodine-deficiency syndrome, myxedematous type
- E00.2Congenital iodine-deficiency syndrome, mixed type
- E00.9Congenital iodine-deficiency syndrome, unspecified
- E01.0Iodine-deficiency related diffuse (endemic) goiter
- E01.1Iodine-deficiency related multinodular (endemic) goiter
- E01.2Iodine-deficiency related (endemic) goiter, unspecified
- E01.8Other iodine-deficiency related thyroid disorders and allied conditions
- E02Subclinical iodine-deficiency hypothyroidism
- E03.0Congenital hypothyroidism with diffuse goiter
- E03.1Congenital hypothyroidism without goiter
- E03.2Hypothyroidism due to medicaments and other exogenous substances
- E03.3Postinfectious hypothyroidism
- E03.4Atrophy of thyroid (acquired)
- E03.8Other specified hypothyroidism
- E03.9Hypothyroidism, unspecified
- E04.0Nontoxic diffuse goiter
- E04.1Nontoxic single thyroid nodule
- E04.2Nontoxic multinodular goiter
- E04.8Other specified nontoxic goiter
- E04.9Nontoxic goiter, unspecified
- E05.00Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm
- E05.01Thyrotoxicosis with diffuse goiter with thyrotoxic crisis or storm
- E05.10Thyrotoxicosis with toxic single thyroid nodule without thyrotoxic crisis or storm
- E05.11Thyrotoxicosis with toxic single thyroid nodule with thyrotoxic crisis or storm
- E05.20Thyrotoxicosis with toxic multinodular goiter without thyrotoxic crisis or storm
- E05.21Thyrotoxicosis with toxic multinodular goiter with thyrotoxic crisis or storm
- E05.30Thyrotoxicosis from ectopic thyroid tissue without thyrotoxic crisis or storm
- E05.31Thyrotoxicosis from ectopic thyroid tissue with thyrotoxic crisis or storm
- E05.40Thyrotoxicosis factitia without thyrotoxic crisis or storm
- E05.41Thyrotoxicosis factitia with thyrotoxic crisis or storm
- E05.80Other thyrotoxicosis without thyrotoxic crisis or storm
- E05.81Other thyrotoxicosis with thyrotoxic crisis or storm
- E05.90Thyrotoxicosis, unspecified without thyrotoxic crisis or storm
- E05.91Thyrotoxicosis, unspecified with thyrotoxic crisis or storm
- E06.0Acute thyroiditis
- E06.1Subacute thyroiditis
- E06.2Chronic thyroiditis with transient thyrotoxicosis
- E06.3Autoimmune thyroiditis
- E06.4Drug-induced thyroiditis
- E06.5Other chronic thyroiditis
- E06.9Thyroiditis, unspecified
- E07.0Hypersecretion of calcitonin
- E07.1Dyshormogenetic goiter
- E07.89Other specified disorders of thyroid
- E07.9Disorder of thyroid, unspecified
- E16.0Drug-induced hypoglycemia without coma
- E16.1Other hypoglycemia
- E16.3Increased secretion of glucagon
- E16.8Other specified disorders of pancreatic internal secretion
- E16.9Disorder of pancreatic internal secretion, unspecified
- E16.A1Hypoglycemia level 1
- E16.A2Hypoglycemia level 2
- E16.A3Hypoglycemia level 3
- E20.0Idiopathic hypoparathyroidism
- E20.810Autosomal dominant hypocalcemia
- E20.811Secondary hypoparathyroidism in diseases classified elsewhere
- E20.812Autoimmune hypoparathyroidism
- E20.818Other specified hypoparathyroidism due to impaired parathyroid hormone secretion
- E20.819Hypoparathyroidism due to impaired parathyroid hormone secretion, unspecified
- E20.89Other specified hypoparathyroidism
- E20.9Hypoparathyroidism, unspecified
- E21.0Primary hyperparathyroidism
- E21.1Secondary hyperparathyroidism, not elsewhere classified
- E21.2Other hyperparathyroidism
- E21.3Hyperparathyroidism, unspecified
- E21.4Other specified disorders of parathyroid gland
- E21.5Disorder of parathyroid gland, unspecified
- E22.0Acromegaly and pituitary gigantism
- E22.1Hyperprolactinemia
- E22.2Syndrome of inappropriate secretion of antidiuretic hormone
- E22.8Other hyperfunction of pituitary gland
- E22.9Hyperfunction of pituitary gland, unspecified
- E23.0Hypopituitarism
- E23.1Drug-induced hypopituitarism
- E23.2Diabetes insipidus
- E23.3Hypothalamic dysfunction, not elsewhere classified
- E23.6Other disorders of pituitary gland
- E23.7Disorder of pituitary gland, unspecified
- E24.0Pituitary-dependent Cushing's disease
- E24.1Nelson's syndrome
- E24.2Drug-induced Cushing's syndrome
- E24.3Ectopic ACTH syndrome
- E24.4Alcohol-induced pseudo-Cushing's syndrome
- E24.8Other Cushing's syndrome
- E24.9Cushing's syndrome, unspecified
- E25.0Congenital adrenogenital disorders associated with enzyme deficiency
- E25.8Other adrenogenital disorders
- E25.9Adrenogenital disorder, unspecified
- E26.01Conn's syndrome
- E26.02Glucocorticoid-remediable aldosteronism
- E26.09Other primary hyperaldosteronism
- E26.1Secondary hyperaldosteronism
- E26.81Bartter's syndrome
- E26.89Other hyperaldosteronism
- E26.9Hyperaldosteronism, unspecified
- E27.0Other adrenocortical overactivity
- E27.1Primary adrenocortical insufficiency
- E27.2Addisonian crisis
- E27.3Drug-induced adrenocortical insufficiency
- E27.40Unspecified adrenocortical insufficiency
- E27.49Other adrenocortical insufficiency
- E27.5Adrenomedullary hyperfunction
- E27.8Other specified disorders of adrenal gland
- E27.9Disorder of adrenal gland, unspecified
- E29.0Testicular hyperfunction
- E29.1Testicular hypofunction
- E29.8Other testicular dysfunction
- E29.9Testicular dysfunction, unspecified
- E30.0Delayed puberty
- E30.1Precocious puberty
- E30.8Other disorders of puberty
- E30.9Disorder of puberty, unspecified
- E31.0Autoimmune polyglandular failure
- E31.1Polyglandular hyperfunction
- E31.20Multiple endocrine neoplasia [MEN] syndrome, unspecified
- E31.21Multiple endocrine neoplasia [MEN] type I
- E31.22Multiple endocrine neoplasia [MEN] type IIA
- E31.23Multiple endocrine neoplasia [MEN] type IIB
- E31.8Other polyglandular dysfunction
- E31.9Polyglandular dysfunction, unspecified
- E34.00Carcinoid syndrome, unspecified
- E34.01Carcinoid heart syndrome
- E34.09Other carcinoid syndrome
- E34.1Other hypersecretion of intestinal hormones
- E34.2Ectopic hormone secretion, not elsewhere classified
- E34.30Short stature due to endocrine disorder, unspecified
- E34.31Constitutional short stature
- E34.321Primary insulin-like growth factor-1 (IGF-1) deficiency
- E34.322Insulin-like growth factor-1 (IGF-1) resistance
- E34.328Other genetic causes of short stature
- E34.329Unspecified genetic causes of short stature
- E34.39Other short stature due to endocrine disorder
- E34.4Constitutional tall stature
- E34.50Androgen insensitivity syndrome, unspecified
- E34.51Complete androgen insensitivity syndrome
- E34.52Partial androgen insensitivity syndrome
- E34.8Other specified endocrine disorders
- E34.9Endocrine disorder, unspecified
- E35Disorders of endocrine glands in diseases classified elsewhere
- E89.0Postprocedural hypothyroidism
- E89.2Postprocedural hypoparathyroidism
- E89.3Postprocedural hypopituitarism
- E89.5Postprocedural testicular hypofunction
- E89.6Postprocedural adrenocortical (-medullary) hypofunction
Chapter 17: Congenital malformations, deformations, chromosomal abnormalities, and genetic disorders
Chapter 18: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Chapter 19: Injury, poisoning and certain other consequences of external causes
- S11.10XAUnspecified open wound of thyroid gland, initial encounter
- S11.11XALaceration without foreign body of thyroid gland, initial encounter
- S11.12XALaceration with foreign body of thyroid gland, initial encounter
- S11.13XAPuncture wound without foreign body of thyroid gland, initial encounter
- S11.14XAPuncture wound with foreign body of thyroid gland, initial encounter
- S11.15XAOpen bite of thyroid gland, initial encounter
- S37.812AContusion of adrenal gland, initial encounter
- S37.813ALaceration of adrenal gland, initial encounter
- S37.818AOther injury of adrenal gland, initial encounter
- S37.819AUnspecified injury of adrenal gland, initial encounter
Common questions about DRG 643
What is the relative weight of DRG 643?
- 1.6139 for FY2027 (MS-DRG v44.0), from the IPPS final rule Table 5.
What is the average length of stay for DRG 643?
- The geometric mean length of stay is 4.8 days; the arithmetic mean is 6.1 days.
Is DRG 643 medical or surgical?
- DRG 643 is a medical DRG.